A Pilot Study to Estimate the Efficacy of Moxibustion Stimulation at Abdominal Acupoints on Quality of Life in Cancer Patients Under Chemotherapy
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 20
- 试验地点
- 1
- 主要终点
- functional Assessment of Cancer Therapy: General (FACT-G)
研究概览
简要总结
Most cancer patients experience multiple symptoms related to chemotherapy and use CAM (complementary and alternative medicine) as an adjunct to conventional treatment. Moxibustion is traditional Korean medical therapeutic method and uses the heat generated by burning herbal preparations containing Artemisia vulgaris to stimulated acupoint.
Herein, the investigators propose an open-label pilot study investigating the effectiveness of moxibustion stimulation at abdominal acupoint on quality of life in cancer patients under chemotherapy.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Supportive Care
- 盲法
- Single (Outcomes Assessor)
入排标准
- 年龄范围
- 20 Years 至 70 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Diagnostic histopathology of cancer
- •Performance status of 0-2 on the European Cooperative Oncology Group (ECOG) performance scale.
- •Patients on chemotherapy currently have plan to receive chemotherapy for more than 6 weeks.
- •Follow-up possible during the clinical trial
- •Informed signed consent
排除标准
- •Patients with Severe Heart disease and hypertension that is not controlled (systolic blood pressure >160 or Diastolic blood pressure >100)
- •Patients with diabetes that is not controlled (FBST >180 or BST>250)
- •Patients with abdominal injury or severe ascites can't be received moxibustion therapy on abdomen.
- •Hypersensitive section to moxibustion treatment
- •Inability to comprehend or express oneself in the Korean language
- •An Individual deemed to be ineligible by a physician
- •Refusal to participate in this trial or to provide informed consent.
研究组 & 干预措施
Moxibustion
A series of moxibustion sessions within six weeks from baseline with adjuvant chemotherapy.
干预措施: Moxibustion (Other)
Waiting
Participants who will be allocated to waitlist will receive no moxibustion treatments throughout the 6 weeks while receiving adjuvant chemotherapy
结局指标
主要结局
functional Assessment of Cancer Therapy: General (FACT-G)
时间窗: change from baseline to 6 weeks
次要结局
- Body mass index(change from baseline to 6 weeks)
- M.D, Anderson symptom Inventory (MDASI)(change from baseline to 6 weeks)
- immune function(change from baseline to 6 weeks)
研究者
Hyun jung, Jung
assistant professor
The Comprehensive and Integrative Medicine Institute of South Korea